Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.01.2018 | Case report

Sofosbuvir

Recurrent hypoglycemia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

A study described a woman [age not stated] who developed recurrent hypoglycaemia during treatment with sofosbuvir. She had a history of hepatitis C with end stage renal disease and decompensated liver cirrhosis. She was scheduled to receive sofosbuvir 200mg once daily [route not stated] for a duration of 24 weeks. She developed recurrence of hypoglycemia [time to reaction onset not stated]. She discontinued therapy at 20 weeks and her condition resolved. …
Literatur
Zurück zum Zitat Gupta A, et al. Sofosbuvir based regimen in management of hepatitis C for patients with end stage renal disease on hemodialysis: A single center experience from India. Journal of Clinical and Experimental Hepatology 7 (Suppl. 2): S25 abstr. 21, Jul 2017. Available from: URL: http://doi.org/10.1016/j.jceh.2017.05.054 [abstract] - India Gupta A, et al. Sofosbuvir based regimen in management of hepatitis C for patients with end stage renal disease on hemodialysis: A single center experience from India. Journal of Clinical and Experimental Hepatology 7 (Suppl. 2): S25 abstr. 21, Jul 2017. Available from: URL: http://​doi.​org/​10.​1016/​j.​jceh.​2017.​05.​054 [abstract] - India
Metadaten
Titel
Sofosbuvir
Recurrent hypoglycemia: case report
Publikationsdatum
01.01.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-40562-0

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Pembrolizumab

Case report

Multiple drugs